Form 4: Nuvalent CDO Exercises Options, Sells Shares

Nuvalent's Chief Development Officer, Darlene Noci, exercised stock options and subsequently sold 4,000 shares of Class A Common Stock under a pre-arranged 10b5-1 trading plan.

Summary

• Darlene Noci, Nuvalent, Inc.'s Chief Development Officer, engaged in transactions on October 30, 2025.
• Noci exercised stock options to acquire 4,000 shares of Class A Common Stock at an exercise price of $27.85 per share.
• Concurrently, Noci sold a total of 4,000 shares of Class A Common Stock in multiple transactions.
• The sale prices for the Class A Common Stock ranged from a weighted average of $98.91 to $104.58 per share.
• All reported transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted by Noci on November 18, 2024.
• Following these transactions, Noci directly owns 48,034 shares of Class A Common Stock and 122,329 stock options.

Sentiment

Score: 6

Explanation: The transactions reflect an insider exercising options and selling shares for a profit under a pre-arranged 10b5-1 plan. While selling reduces direct holdings, the planned nature and profitability are neutral to slightly positive, as it's a routine financial event for executives.

Positives

• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating planned activity rather than reactive selling, which can be viewed as a prudent financial management strategy.
• The sale prices for the Class A Common Stock were significantly higher than the option exercise price of $27.85, indicating a substantial profit for the insider on these specific transactions.

Negatives

• An insider selling shares, even under a 10b5-1 plan, can sometimes be perceived negatively by the market, potentially suggesting a belief that the stock's near-term upside is limited from the insider's perspective.

Future Outlook

This Form 4 filing reports historical insider transactions and does not contain any forward-looking statements or guidance regarding Nuvalent, Inc.'s future performance or strategic outlook.

Industry Context

This filing is a routine insider transaction report and does not provide specific information to analyze broader industry trends or competitive positioning. It reflects an individual executive's personal financial planning.

Stakeholder Impact

• Shareholders: May view the insider sale with mixed feelings; some might interpret it as a signal, while others will recognize it as a routine diversification or liquidity event under a pre-established plan, which typically mitigates negative perceptions.

Next Steps

• The remaining 122,329 stock options held by Darlene Noci will continue to vest over the four years following January 6, 2023, subject to continued service to Nuvalent, Inc.

Key Dates

Recommendation

This filing details routine insider transactions (option exercise and subsequent sale) executed under a pre-established 10b5-1 trading plan. Such transactions are generally for personal financial planning or diversification and are not typically considered a strong indicator for future stock performance. Therefore, a 'hold' recommendation is appropriate as this filing does not provide new fundamental information to alter an investment thesis.

Keywords

Nuvalent, NUVL, Form 4, Insider Trading, Stock Options, Share Sale, Darlene Noci, Chief Development Officer, 10b5-1 Plan